Status:
ACTIVE_NOT_RECRUITING
Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19)
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Coronavirus Infections
Eligibility:
All Genders
18+ years
Brief Summary
Establishment of a biological bank of subjects vaccinated against SARS-Cov-2 infection (COVID-BioVac)
Detailed Description
The purpose of the COVID-BioVac study is to establish a biobank of biological samples from subjects who have received the anti-SARS-CoV-2 vaccine, with the ultimate aim (following approval by the EC o...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Who have vaccinated for SARS-CoV-2 with Pfizer-BioNTech vaccine or others
- Signing of informed consent from January to March 2021
Exclusion
- none
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT05276388
Start Date
January 1 2021
End Date
March 31 2026
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Milano, Italy, 20132